These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35467486)

  • 1. Evaluation of phytoconstituents of
    Choudhary P; Singh T; Amod A; Singh S
    J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting COVID-19 (SARS-CoV-2) main protease through active phytocompounds of ayurvedic medicinal plants - Emblica officinalis (Amla), Phyllanthus niruri Linn. (Bhumi Amla) and Tinospora cordifolia (Giloy) - A molecular docking and simulation study.
    Murugesan S; Kottekad S; Crasta I; Sreevathsan S; Usharani D; Perumal MK; Mudliar SN
    Comput Biol Med; 2021 Sep; 136():104683. PubMed ID: 34329860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus
    Abouelela ME; Assaf HK; Abdelhamid RA; Elkhyat ES; Sayed AM; Oszako T; Belbahri L; El Zowalaty AE; Abdelkader MSA
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Therapeutic Potential of
    Ali MA; Sheikh H; Yaseen M; Faruqe MO; Ullah I; Kumar N; Bhat MA; Mollah MNH
    Molecules; 2024 May; 29(11):. PubMed ID: 38893400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach.
    Kushwaha PP; Singh AK; Bansal T; Yadav A; Prajapati KS; Shuaib M; Kumar S
    Front Cell Infect Microbiol; 2021; 11():730288. PubMed ID: 34458164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study.
    Uzuner U; Akkus E; Kocak A; Çelik Uzuner S
    J Biomol Struct Dyn; 2024 Aug; 42(13):6892-6903. PubMed ID: 37458994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching possible SARS-CoV-2 main protease inhibitors in constituents from herbal medicines using
    Rasul HO; Thomas NV; Ghafour DD; Aziz BK; Salgado M G; Mendoza-Huizar LH; Candia LG
    J Biomol Struct Dyn; 2024 May; 42(8):4234-4248. PubMed ID: 37349945
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sharma P; Joshi T; Joshi T; Mathpal S; Maiti P; Nand M; Chandra S; Tamta S
    J Biomol Struct Dyn; 2023 Feb; 41(2):646-658. PubMed ID: 34854365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of phytochemical compounds of
    Krupanidhi S; Abraham Peele K; Venkateswarulu TC; Ayyagari VS; Nazneen Bobby M; John Babu D; Venkata Narayana A; Aishwarya G
    J Biomol Struct Dyn; 2021 Sep; 39(15):5799-5803. PubMed ID: 32627715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease.
    Deshmukh N; Talkal R; Lakshmi B
    J Biomol Struct Dyn; 2024 Jun; 42(9):4395-4411. PubMed ID: 37325819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods.
    Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S
    J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by
    Bhowmick S; Mistri TK; Khan MR; Patil PC; Busquets R; Ashif Ikbal AM; Choudhury A; Roy DK; Palit P; Saha A
    J Biomol Struct Dyn; 2024 Sep; 42(14):7107-7127. PubMed ID: 37482789
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2024; 21(3):73-89. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADMET profile and virtual screening of plant and microbial natural metabolites as SARS-CoV-2 S1 glycoprotein receptor binding domain and main protease inhibitors.
    Padhi S; Masi M; Chourasia R; Rajashekar Y; Rai AK; Evidente A
    Eur J Pharmacol; 2021 Jan; 890():173648. PubMed ID: 33069672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ayurveda botanicals in COVID-19 management: An in silico multi-target approach.
    Borse S; Joshi M; Saggam A; Bhat V; Walia S; Marathe A; Sagar S; Chavan-Gautam P; Girme A; Hingorani L; Tillu G
    PLoS One; 2021; 16(6):e0248479. PubMed ID: 34115763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M
    Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F
    Eur Biophys J; 2024 Aug; 53(5-6):277-298. PubMed ID: 38907013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
    El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.